Skip to main content
. 2008 Feb 6;12(5a):1535–1547. doi: 10.1111/j.1582-4934.2008.00250.x

2.

Percentage of SELDI-MS studies performed to date (Mid Jan 2007)

Cancer type % of studies
Breast 16.3%
Colon 3.6%
Colorectal 8.2%
Glioma 2.8%
Hepatocellular/liver 8.9%
Kidney/renal 4.1%
Laryngeal 0.4%
Leukaemia/CLMC 2%
Ovarian 10.2%
Thyroid 1.2%
Bladder 4.1%
Pancreas 2.8%
Lung 2.8%
Head and neck 4%
Endometrial 1.6%
Brain 1.2%
Melanoma 1.6%